GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

Symbol: TRDA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$6,580,002	639,947	-5,172	-0.8%	$10.28	Q4 2025
30 Sep 2025	0%	+0%	$3,742,489	645,119	+13,565	+2.1%	$5.80	Q3 2025
30 Jun 2025	0%	+0%	$4,244,897	631,554	+42,479	+7.2%	$6.72	Q2 2025
31 Mar 2025	0%	+0%	$5,326,635	589,075	+15,184		$9.04	Q1 2025
31 Dec 2024	0%	-0%	$9,925,236	573,891	-2,560	-0.44%	$17.29	Q4 2024
30 Sep 2024	0%	+0%	$9,213,669	576,451	+46,512	+8.8%	$15.98	Q3 2024
30 Jun 2024	0%	+0%	$7,552,580	529,939	+54,581	+11%	$14.25	Q2 2024
31 Mar 2024	0%	+0%	$6,736,526	475,358	+15,977	+3.5%	$14.17	Q1 2024
31 Dec 2023	0%	+0%	$6,932,745	459,381	+20,800	+4.7%	$15.09	Q4 2023
30 Sep 2023	0%	+0%	$6,930,372	438,581	+37,950	+9.5%	$15.80	Q3 2023
30 Jun 2023	0%	+0%	$6,065,553	400,631	+216,841	+118%	$15.14	Q2 2023
31 Mar 2023	0%	+0%	$2,664,955	183,790	+1,833	+1%	$14.50	Q1 2023
31 Dec 2022	0%	+0%	$2,460,000	181,957	+14,839	+8.9%	$13.52	Q4 2022
30 Sep 2022	0%	+0%	$2,633,000	167,118	+65,347	+64%	$15.76	Q3 2022
30 Jun 2022	0%	-0%	$1,239,000	101,771	-75,962	-43%	$12.17	Q2 2022
31 Mar 2022	0%	+0%	$1,668,000	177,733	+15,546	+9.6%	$9.38	Q1 2022
31 Dec 2021	0%	+0%	$2,776,000	162,187	+162,187	NEW	$17.12	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.